These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 20369150)
1. Abnormal Pap tests after the HPV vaccine. Heley S; Brotherton J Aust Fam Physician; 2009 Dec; 38(12):977-9. PubMed ID: 20369150 [TBL] [Abstract][Full Text] [Related]
2. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221 [TBL] [Abstract][Full Text] [Related]
3. Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program. Donken R; van Niekerk D; Hamm J; Spinelli JJ; Smith L; Sadarangani M; Albert A; Money D; Dobson S; Miller D; Lee M; Mitchell-Foster S; Krajden M; Naus M; Ogilvie G Int J Cancer; 2021 Jul; 149(1):191-199. PubMed ID: 33586169 [TBL] [Abstract][Full Text] [Related]
4. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Dillner J; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Maansson R; Lu S; Vuocolo S; Hesley TM; Saah A; Barr E; Haupt RM Cancer Prev Res (Phila); 2009 Oct; 2(10):868-78. PubMed ID: 19789295 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. FUTURE II Study Group J Infect Dis; 2007 Nov; 196(10):1438-46. PubMed ID: 18008221 [TBL] [Abstract][Full Text] [Related]
6. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination. Malo TL; Perkins RB; Lee JH; Vadaparampil ST Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046 [TBL] [Abstract][Full Text] [Related]
7. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ; MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109 [TBL] [Abstract][Full Text] [Related]
8. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia. Brotherton JM; Mullins RM Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834 [TBL] [Abstract][Full Text] [Related]
9. A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Giles M; Garland S Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):311-5. PubMed ID: 16866792 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada. Mahmud SM; Kliewer EV; Lambert P; Bozat-Emre S; Demers AA J Clin Oncol; 2014 Feb; 32(5):438-43. PubMed ID: 24395857 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Paavonen J; Naud P; Salmerón J; Wheeler CM; Chow SN; Apter D; Kitchener H; Castellsague X; Teixeira JC; Skinner SR; Hedrick J; Jaisamrarn U; Limson G; Garland S; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Jenkins D; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G; Lancet; 2009 Jul; 374(9686):301-14. PubMed ID: 19586656 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study. Rodriguez AM; Zeybek B; Vaughn M; Westra J; Kaul S; Montealegre JR; Lin YL; Kuo YF Cancer; 2020 Apr; 126(8):1656-1667. PubMed ID: 32037524 [TBL] [Abstract][Full Text] [Related]
14. Pap test update. Heley S Aust Fam Physician; 2007 Mar; 36(3):112-5. PubMed ID: 17339970 [TBL] [Abstract][Full Text] [Related]
15. Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females. Hirth JM; Lin YL; Kuo YF; Berenson AB Prev Med; 2016 Jul; 88():134-9. PubMed ID: 27085993 [TBL] [Abstract][Full Text] [Related]
16. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519 [TBL] [Abstract][Full Text] [Related]
17. Cancers attributable to human papillomavirus infection. Grulich AE; Jin F; Conway EL; Stein AN; Hocking J Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211 [TBL] [Abstract][Full Text] [Related]
18. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Villa LL; Costa RL; Petta CA; Andrade RP; Paavonen J; Iversen OE; Olsson SE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; Krogh Gv; Lehtinen M; Malm C; Tamms GM; Giacoletti K; Lupinacci L; Railkar R; Taddeo FJ; Bryan J; Esser MT; Sings HL; Saah AJ; Barr E Br J Cancer; 2006 Dec; 95(11):1459-66. PubMed ID: 17117182 [TBL] [Abstract][Full Text] [Related]